For: | Chang SC, Lin JK, Lin TC, Liang WY. Loss of heterozygosity: An independent prognostic factor of colorectal cancer. World J Gastroenterol 2005; 11(6): 778-784 [PMID: 15682467 DOI: 10.3748/wjg.v11.i6.778] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i6/778.htm |
Number | Citing Articles |
1 |
Turkan Aytekin, Mehmet Ozaslan, Beyhan Cengiz. Deletion mapping of chromosome region 12q13-24 in colorectal cancer. Cancer Genetics and Cytogenetics 2010; 201(1): 32 doi: 10.1016/j.cancergencyto.2010.05.005
|
2 |
Xin‐Min Xu, Jian‐Chang Qian, Zhe Cai, Tao Tang, Peng Wang, Ke‐Hua Zhang, Zhou‐Lu Deng, Jian‐Ping Cai. DNA alterations of microsatellite DNA, p53, APC and K‐ras in Chinese colorectal cancer patients. European Journal of Clinical Investigation 2012; 42(7): 751 doi: 10.1111/j.1365-2362.2011.02641.x
|
3 |
Martine Muleris, Alexandra Chalastanis, Nicolas Meyer, Marick Lae, Bernard Dutrillaux, Xavier Sastre-Garau, Richard Hamelin, Jean-Francois Fléjou, Alex Duval, Dong-Yan Jin. Chromosomal Instability in Near-Diploid Colorectal Cancer: A Link between Numbers and Structure. PLoS ONE 2008; 3(2): e1632 doi: 10.1371/journal.pone.0001632
|
4 |
Peng Du, Bin Xu, Dachuan Zhang, Yingjie Shao, Xiao Zheng, Xiaodong Li, Yuqi Xiong, Changping Wu, Jingting Jiang. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma. Oncotarget 2017; 8(1): 954 doi: 10.18632/oncotarget.13512
|
5 |
Babu V. Sajesh, Amy L. Cisyk, Kirk J. McManus. Genomic Instability and Cancer Metastasis. Cancer Metastasis - Biology and Treatment 2015; 20: 179 doi: 10.1007/978-3-319-12136-9_9
|
6 |
Monica M. Bertagnolli. Interpreting the Inconsistent Data Concerning the Role of 18qLOH as a Prognostic Marker for Colorectal Cancer. Current Colorectal Cancer Reports 2010; 6(3): 158 doi: 10.1007/s11888-010-0060-3
|
7 |
Takashi Akiyoshi, Takashi Kobunai, Toshiaki Watanabe. Recent approaches to identifying biomarkers for high-risk stage II colon cancer. Surgery Today 2012; 42(11): 1037 doi: 10.1007/s00595-012-0324-4
|
8 |
Koji Matsuzaki, Guoren Deng, Hirofumi Tanaka, Sanjay Kakar, Soichiro Miura, Young S. Kim. The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer. Clinical Cancer Research 2005; 11(24): 8564 doi: 10.1158/1078-0432.CCR-05-0859
|
9 |
NASIR KAMAT, MOHAMMED A. KHIDHIR, MOUIED M. ALASHARI, ULF RANNUG. Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study. Oncology Letters 2013; 6(5): 1413 doi: 10.3892/ol.2013.1573
|
10 |
Amy L. Cisyk, Harminder Singh, Kirk J. McManus. Establishing a Biological Profile for Interval Colorectal Cancers. Digestive Diseases and Sciences 2014; 59(10): 2390 doi: 10.1007/s10620-014-3210-7
|
11 |
Tamrin Chowdhury, Yongjin Yoo, Youngbeom Seo, Yun-Sik Dho, Sojin Kim, Anna Choi, Murim Choi, Sung-Hye Park, Chul-Kee Park, Sang Hyung Lee, Ji Yeoun Lee. Genomic analysis of synchronous intracranial meningiomas with different histological grades. Journal of Neuro-Oncology 2018; 138(1): 41 doi: 10.1007/s11060-018-2772-1
|
12 |
Gershon Y. Locker, Stanley Hamilton, Jules Harris, John M. Jessup, Nancy Kemeny, John S. Macdonald, Mark R. Somerfield, Daniel F. Hayes, Robert C. Bast. ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer. Journal of Clinical Oncology 2006; 24(33): 5313 doi: 10.1200/JCO.2006.08.2644
|
13 |
John N. McMahon, Eoin F. Gaffney, William J. Aliaga-Kelly, John F. Stephens, Amirhossein Jalali, Bernadette Curran. P53 loss of heterozygosity (LOH) in formalin-fixed paraffin-embedded leiomyosarcoma (LMS): a novel report. Irish Journal of Medical Science (1971 -) 2024; 193(1): 65 doi: 10.1007/s11845-023-03370-1
|
14 |
Xueyun Huo, Dandan Feng, Shuangyue Zhang, Zhenkun Li, Xiaohong Li, Changlong Li, Meng Guo, Jin Wang, Zhongtao Zhang, Qingxian Lu, Xiaoyan Du, Zhigang Bai, Zhenwen Chen. Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity within tumor-related genes in colorectal cancer. BMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-021-01051-5
|
15 |
Monika Berbecka, Maciej Berbecki, Anna Maria Gliwa, Monika Szewc, Robert Sitarz. Managing Colorectal Cancer from Ethology to Interdisciplinary Treatment: The Gains and Challenges of Modern Medicine. International Journal of Molecular Sciences 2024; 25(4): 2032 doi: 10.3390/ijms25042032
|
16 |
BIN CAI, ZHIXIAN LIU, YANSONG XU, WEIYUAN WEI, SEN ZHANG. Adenoma detection rate in 41,010 patients from Southwest China. Oncology Letters 2015; 9(5): 2073 doi: 10.3892/ol.2015.3005
|
17 |
Mukesh Verma, Daniela Seminara, Fernando J. Arena, Christy John, Kumiko Iwamoto, Virginia Hartmuller. Genetic and Epigenetic Biomarkers in Cancer. Molecular Diagnosis & Therapy 2006; 10(1): 1 doi: 10.1007/BF03256438
|
18 |
Nives Pećina-Šlaus, Tamara Nikuševa Martić, Martina Zeljko, Sandra Bulat. Brain metastases exhibit gross deletions of the APC gene. Brain Tumor Pathology 2011; 28(3): 223 doi: 10.1007/s10014-011-0030-8
|
19 |
Mukesh Verma, Upender Manne. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations. Critical Reviews in Oncology/Hematology 2006; 60(1): 9 doi: 10.1016/j.critrevonc.2006.04.002
|
20 |
I. Oikonomakis. Colorectal cancer: The issue of uniformity throughout the colon in light of molecular marker expression. Hellenic Journal of Surgery 2011; 83(2): 57 doi: 10.1007/s13126-011-0011-8
|
21 |
Giulia Rizzo, Andrea Bertotti, Simonetta Maria Leto, Stefania Vetrano. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01970-2
|
22 |
Monica M. Bertagnolli, Mark Redston, Carolyn C. Compton, Donna Niedzwiecki, Robert J. Mayer, Richard M. Goldberg, Thomas A. Colacchio, Leonard B. Saltz, Robert S. Warren. Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803. Journal of Clinical Oncology 2011; 29(23): 3153 doi: 10.1200/JCO.2010.33.0092
|
23 |
Kim M Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar, Drew Watson. Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX®Colon Cancer Assay. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-691
|
24 |
Ana María Wielandt, Claudia Hurtado, Mauricio Moreno C, Cynthia Villarroel, Magdalena Castro, Marlene Estay, Daniela Simian, Maripaz Martinez, Maria Teresa Vial, Udo Kronberg, Francisco López-Köstner. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Tumor Biology 2020; 42(7): 101042832093849 doi: 10.1177/1010428320938492
|
25 |
Lei Song, Krithika Bhuvaneshwar, Yue Wang, Yuanjian Feng, Ie-Ming Shih, Subha Madhavan, Yuriy Gusev. CINdex: A Bioconductor Package for Analysis of Chromosome Instability in DNA Copy Number Data. Cancer Informatics 2017; 16: 117693511774663 doi: 10.1177/1176935117746637
|
26 |
Paula Lázcoz, Jorge Muñoz, Manuel Nistal, Ángel Pestaña, Ignacio Encío, Javier S Castresana. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma. BMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-254
|
27 |
Audrey Killian, Frédéric Di Fiore, Florence Le Pessot, France Blanchard, Aude Lamy, Grégory Raux, Jean–Michel Flaman, Bernard Paillot, Pierre Michel, Jean–Christophe Sabourin, Jean–Jacques Tuech, Francis Michot, Jean–Pierre Kerckaert, Richard Sesboüé, Thierry Frebourg. A Simple Method for the Routine Detection of Somatic Quantitative Genetic Alterations in Colorectal Cancer. Gastroenterology 2007; 132(2): 645 doi: 10.1053/j.gastro.2006.12.006
|
28 |
Voke Peter Orugbo, Esaba Emmanuel Akpo. Metabolic changes in colorectal carcinomas are key factors for the early detection of neoplastic change. Annals of Clinical and Biomedical Research 2021; 2(2) doi: 10.4081/acbr.2021.134
|
29 |
Jennifer A. Fairley, Zandra C. Deans, Rebecca J. L. Treacy, Eilidh Grieg, Kathryn Bungartz, Ruth Burton, James Hayes, Sheryl K. Elkin. An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment. Journal of Molecular Pathology 2022; 3(3): 125 doi: 10.3390/jmp3030012
|
30 |
Geoffrey G. Liu, Wei Zhou, Zhaoxi Wang, Howard L. McLeod. TNM Online. 2006; doi: 10.1002/0471463736.tnmp49
|